New psychoactive substances in England: a review of the evidence. [PDF]
Aims and approach: This report builds on chapter 2 of the report of the expert panel review, and provides an overview of the current available evidence on New Psychoactive Substances (NPS)1. Conclusion: • NPS is a new and developing area of study.
Richardson, Anna, Stephenson, Giles
core
The challenge of synthetic drugs in East and South-East Asia and Oceania [PDF]
The demand for synthetic drugs in East and Southeast Asia and Oceania continues to rise, while rapid economic integration is creating new opportunities for transnational criminal groups to expand the illicit drug trade, warns the United Nations Office on
Justice Tettey
core
Generic bans of new psychoactive substances [PDF]
New psychoactive substances attract attention of the researchers for more than ten years. Their appearance and increasing presence in the drug market require an adequate response from all responsible state authorities.
Risimović Radosav S.
doaj
Towards a safer drug policy: challenges and opportunities arising from ‘legal highs’. [PDF]
The All-Party Parliamentary Group for Drug Policy Reform launches the Report of its Inquiry into New Psychoactive Substances ('legal highs') on the 14th January 2013. The Inquiry began in 2011 and was initiated in response to the rapid development of new
core
THE EVOLVING THREAT OF NEW PSYCHOACTIVE SUBSTANCES (NPS)
New psychoactive substances (NPS) have become a worldwide phenomenon, and there are now over 134 countries and territories that have reported NPS worldwide. Since December 2021, there have been confirmations made by the UNODC Early Warning Advisory concerning EWA of NPS of more than 1124 substances.
openaire +1 more source
New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017. [PDF]
Hondebrink L +5 more
europepmc +1 more source
Global Overview of Drug Demand and Supply: Latest Trends, Cross-cutting Issues [PDF]
An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population ...
core
Forensic Toxicology: Advances in the Identification of New Psychoactive Substances (NPS)
New Psychoactive Substances is one of the biggest challenges for forensic toxicology. Artificially manufactured drugs that are aimed at mimicking the effects of substances that are under legal regulations commonly present unique challenges regarding identification and ...
openaire +1 more source
AI Methods for New Psychoactive Substance (NPS) Design and Analysis
Over the past decade, more than a thousand new psychoactive substances (NPSs) have emerged worldwide. This rapid proliferation of “designer drugs” poses significant challenges for drug control, forensic analysis, and public health. Artificial intelligence (AI) has increasingly been applied to address these challenges in NPS design and analysis.
openaire +3 more sources
Prohibition is a key driver of the new psychoactive substances (
Stephen, Rolles, Danny, Kushlick
openaire +2 more sources

